Cureus. 2024 Dec 16;16(12):e75799. doi: 10.7759/cureus.75799. eCollection 2024 Dec.
ABSTRACT
Congenital intracranial hemangiomas are rare benign vascular tumors that develop before birth. Although various treatments, including surgery, steroids, interferon-α, thalidomide, bevacizumab, or propranolol, have been reported, no standard therapy has been established. We report the case of a neonate with congenital intracranial hemangioma and central nervous system symptoms requiring therapeutic intervention. Early postnatal oral propranolol treatment was safe and effective. The neurological prognosis is good post-treatment; however, follow-up is needed to determine the long-term neurological prognosis.
PMID:39816278 | PMC:PMC11734640 | DOI:10.7759/cureus.75799
